There are relatively few studies investigating the alteration of NT-proBNP levels with respect to monitor the treatment in PH patients and no study to date has directly evaluated the effect of oral vasodilators in COPD induced PH patient’s RV function with NT-proBNP. The gene discussed is NPPB; the disease is chronic obstructive pulmonary disease.